Search

MeHg is one of the environmental pollutants that lead to oxidative stress and an indirect excitotoxicity caused by altered glutamate (Glu) concentration. However, little was known of the interaction. Therefore, we developed a rat model of MeHg poisoning to explore its neurotoxic effects, and whether LA could attenuate MeHg-induced neurotoxicity. Seventy-two rats were randomly divided into four groups: control group, MeHg-treated groups (4 and 12 μmol/kg), and LA pre-treatment group. Administration of the 12 μmol/kg MeHg for 4 weeks significantly increased ROS formation that might be critical to aggravate oxidative damages in cerebral cortex. Meanwhile, Glu metabolism as well as GLAST and GLT-1 appeared to be disrupted by MeHg exposure. Pre-treatment of the 35 μmol/kg LA significantly prevented MeHg-induced oxidative stress and Glu dyshomoestasis. In conclusion, findings indicated that MeHg could induce oxidative stress and Glu uptake/metabolism disorders in cerebral cortex, LA might antagonize these neurotoxic effects induced by MeHg. [ABSTRACT FROM AUTHOR]

Abstract: Methylmercury (MeHg) is one of the ubiquitous environmental toxicants, which can induce oxidative stress and an indirect excitotoxicity caused by altered glutamate (Glu) metabolism. However, little is known of the interaction between oxidative stress and Glu metabolism play in MeHg poisoning rats. We have investigated the neuroprotective role of MK-801, a non-competitive N-methyl-d-aspartate receptors (NMDAR) antagonist, against MeHg-induced neurotoxicity. Fifty rats were randomly divided into five groups of 10 animals in each group: control group, MK-801 control group, MeHg-treated group (4 and 12μmol/kg) and MK-801 pre-treated group. Administration of MeHg at a dose of 12μmol/kg for four weeks significantly increased in ROS and total Hg levels and that caused lipid, protein and DNA peroxidative damage in cerebral cortex. In addition, MeHg also reduced nonenzymic (reduced glutathione, GSH) and enzymic (glutathione peroxidase, GPx and superoxide dismutase, SOD) antioxidants and enhanced neurocyte apoptosis rate in cerebral cortex. MeHg-induced ROS production appears to inhibit the activity of the glutamine synthetase (GS), leading to Glu metabolism dysfunction. Pretreatment with MK-801 at a dose of 0.3μmol/kg prevented the alterations of the activities of PAG and GS and oxidative stress. In addition, pretreatment with MK-801 significantly alleviated the neurocyte apoptosis rate and histopathological damage. In conclusion, the results suggested ROS formation resulting from MeHg- and Glu-induced oxidative stress contributed to neuronal injury. MK-801 possesses the ability to attenuate MeHg-induced neurotoxicity in the cerebral cortex through mechanisms involving its NMDA receptor binding properties and antioxidation. [Copyright &y& Elsevier]

Abstract: Manganese (Mn) is one of the ubiquitous environmental pollutants that can induce an indirect excitotoxicity caused by altered glutamate (Glu) metabolism. The present study has been carried out to investigate the mechanisms of Glu metabolism disorder and the neuroprotective role of MK-801, a non-competitive N-methyl-d-aspartate receptor antagonist, against Mn-induced excitotoxicity in rat striatum. Fifty rats were randomly divided into five groups with 10 animals in each group: control group, Mn-treated group (8, 40, and 200μmol/kg), and MK-801-pre-treated group. Administration of MnCl2·6H2O at dose of 200μmol/kg body weight for 4 weeks significantly increased the concentrations of Glu and Mn in the striatum (P<0.01). In addition, Mn also increased the activity of phosphate-activated glutaminase (PAG) (54.38%, P<0.01), enhanced striatum cell apoptosis rate (65.04%, P<0.01) and decreased the activity of glutamine synthetase (GS) (28.88%, P<0.01). Pre-treatment with MK-801 at a dose of 0.3μmol/kg body weight for 4 weeks prior to 200μmol/kg Mn administration prevents the alterations of the activities of PAG and GS and concentrations of glutamine (Gln). In addition, pre-treatment with MK-801 significantly reduced the striatum cell apoptosis rate. In conclusion, the results suggest that MK-801 possesses the ability to attenuate Mn-induced Glu metabolism disorder in the striatum through mechanisms involving disruption enzyme activities of GS and PAG. [Copyright &y& Elsevier]

Abstract: Overexposure to cadmium (Cd) can induce kidney damage, which was related to the oxidative damage and disturb intracellular Ca2+ homeostasis. Chlorpromazine (CPZ), targeting calmodulin (CaM), and the Ca2+ channel blocker Verapamil (Ver) are involved in intracellular Ca2+ homeostasis processes. The aim of the study was to investigate the kidney damage caused by Cd administrated for 6 weeks and to evaluate the effects of pre-treatment with either chlorpromazine or verapamil on Cd-induced kidney damage. Thirty-two Wistar rats were divided randomly into 4 groups by weight, i.e., control group, Cd-treated group, and CPZ or Ver pre-treated group. The Cd-treated group rats were subcutaneously (s.c.) injected with 7μmol CdCl2/kg body weight/day. The CPZ and Ver pre-treated group rats were intraperitoneally (i.p.) injected with 5mg CPZ/kg body weight/day, 4mg Ver/kg body weight/day, respectively, 1h before the s.c. administration of 7μmol CdCl2/kg body weight/day. The control group rats were injected s.c. with saline at the same time. The volume of injection was 2ml/kg body weight, 5 times per week, for up to 6 weeks. After 6 weeks, Cd concentrations in the renal cortex and urine were significantly higher in Cd-treated group than that in controls. Cd concentrations of the urine in CPZ and Ver pre-treated groups were significantly lower than that in Cd-treated group, but there were no significant changes in the renal cortex. Compared with the controls, urinary NAG, ALP activities, and the levels of GSH, MDA, and the activities of PKC, Na+–K+-ATPase, and Ca2+-ATPase in rats from the Cd-treated group were significantly increased. SOD activity was suppressed by Cd. Urinary NAG activity and the level of GSH and the activities of PKC and Ca2+-ATPase in both CPZ and Ver pre-treated groups were significantly lower than that in Cd-treated rats. The present results showed that Cd-induced kidney damage was related to the oxidative damage and disturb intracellular Ca2+ homeostasis. Both CPZ and Ver possess some ability to prevent cadmium-induced kidney damage via antioxidative action and by maintaining calcium homeostasis. [Copyright &y& Elsevier]

Abstract: Overexposure to manganese (Mn) has been known to induce neuronal damage. However, the mechanisms of Mn-induced neuronal cell death are incompletely understood. The objective of this study is to explore mechanisms that contribute to Mn-induced neuronal apoptosis focusing on the alteration of intracellular Ca2+ homeostasis and expression of NMDA receptor subunits in primary cultured neurons. Treatment of neuronal cells with Mn (0–400μM) for 6–48h resulted in the damages of primary cultured neurons concentration- and time-dependently, which were determined by methyl thiazolyl tetrazolium (MTT) and lactate dehydrogenase (LDH) release assay and supported by morphological examination. After neurons treated with Mn (25, 100, 400μM) for 12h, there was a significant increase in apoptosis rate [Ca2+] i and decrease in Na+–K+-ATPase and Ca2+-ATPase activities in a concentration-dependent manner. Moreover, Mn could inhibit expression of NMDA receptor subunits in neuron and expression of NR2A mRNA and protein were much more sensitive to Mn than those of NR1 and NR2B. In conclusion, the present results showed that Mn-induced neuronal damage by increasing [Ca2+] i and altering expression of NMDA receptor subunits mRNAs and proteins. [Copyright &y& Elsevier]

Highlights: [•] Mn could cause nerve cell damage in a time-dependent manner. [•] ER stress signaling was involved in Mn-induced neurotoxicity. [•] Mn induced the ER stress via activation of PERK and IRE1 signaling pathways. [ABSTRACT FROM AUTHOR]

Abstract: Overexposure to manganese (Mn) has been known to induce neuronal damage. However, little is known of the role that reactive oxygen species (ROS) play in protein aggregation resulting from Mn exposure. The current study investigated whether oxidative stress is involved in manganese-induced alpha-synuclein oligomerization in organotypic brain slices. After application of Mn (0–400μM) for 24h, there was a dose-dependent increase in average percentage of propidium iodide positive (PI+) nuclei in slices and levels of lactate dehydrogenase (LDH) in the culture medium. Moreover, the treatment with Mn resulted in a dose-dependent increase in neurocyte apoptosis, ROS level, and decrease in superoxide dismutase (SOD) activity. Mn also caused oxidative damage in cell lipid and protein. At the same time, the exposure of Mn leaded to significantly increase in the expression of alpha-synuclein mRNA and protein. Alpha-synuclein oligomerization occurred in Mn-treated slices, especially on membrane-bound form. It indicated that alpha-synuclein oligomers were more likely to combination cell membranes and resulting in membrane damage. Mn-induced neurocyte damage and alpha-synuclein oligomerization were also partially alleviated by the pretreatment with GSH and aggravated by H2O2 pretreatment. The findings revealed Mn might exert its neurotoxic effects by oxidative stress-mediated alpha-synuclein oligomerization in organotypic brain slices. [Copyright &y& Elsevier]